Showing results (61-70 of 785) with videos related to
Sort By:
Pageof 79
International Journal of Molecular Sciences|April 12, 2022
In Silico and In Vitro Screening of 50 Curcumin Compounds as EGFR and NF-κB InhibitorsMohamed E M Saeed, Rümeysa Yücer, Mona Dawood, et al.Pharmacological Research|April 15, 2023
Pomiferin targets SERCA, mTOR, and P-gp to induce autophagic cell death in apoptosis-resistant cancer cells, and reverses the MDR phenotype in cisplatin-resistant tumors in vivoYuan-Qing Qu, Lin-Lin Song, Su-Wei Xu, et al.European Journal of Medicinal Chemistry|July 13, 2021
Synthesis, computational docking and biological evaluation of celastrol derivatives as dual inhibitors of SERCA and P-glycoprotein in cancer therapyPaolo Coghi, Jerome P L Ng, Onat Kadioglu, et al.Journal of Ethnopharmacology|July 19, 2011
Pharmacogenomics of Cameroonian traditional herbal medicine for cancer therapyVictor Kuete, Thomas EfferthFrontiers in Pharmacology|August 12, 2011
Cameroonian medicinal plants: pharmacology and derived natural productsVictor Kuete, Thomas EfferthMolecular Medicine Reports|April 12, 2011
Human cytomegalovirus: Drug resistance and new treatment options using natural productsSilviya Stoeva, Thomas EfferthCurrent Neuropharmacology|November 12, 2016
Pharmacogenetics and Pharmacotherapy of Military Personnel Suffering from Post-traumatic Stress DisorderJanine Naß, Thomas EfferthIn Vivo (Athens, Greece)|March 31, 2005
Glutathione-related enzymes contribute to resistance of tumor cells and low toxicity in normal organs to artesunateThomas Efferth, Manfred VolmExperimental Hematology & Oncology|December 12, 2012
Polo-like kinase 1 as target for cancer therapyLily Weiß, Thomas EfferthPharmacological Research|May 18, 2019
Development of artemisinin resistance in malaria therapyJanine Naß, Thomas EfferthPageof 79